CMT3 alters mitochondrial function in murine osteoclast lineage cells

Simon Holmes, Susan Smith, Lee Borthwick, James Edward Dunford, Mike Rogers, Nick Bishop, Peter S. Grabowski

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    Chemically modified tetracyclines (CMTs 1-10) were developed as non-antibiotic inhibitors of matrix metalloproteinases (MMPs). We previously demonstrated that MMP inhibition alone is insufficient to explain the pro-apoptotic action of CMTs in osteoclast lineage cells and we have explored additional mechanisms of action. We compared the characteristics of apoptosis in RAW264.7 murine monocyte and osteoclast cultures treated with pharmacologically relevant concentrations of CMT3 or the bisphosphonate alendronate, which induces osteoclast apoptosis through inhibition of farnesyl diphosphate synthase. CMT3 induced apoptosis rapidly (2-3 h), whereas alendronate-induced apoptosis was delayed (>12 h). CMT3-treated cells did not accumulate unprenylated Rap1A in contrast to cells treated with alendronate. Importantly, CMT3 induced a rapid loss of mitochondrial stability in RAW264.7 cells measured by loss of Mitotracker(R) Red fluorescence, while bongkrekic acid protected polykaryons from CMT3-induced apoptosis. Modulation of mitochondrial function is therefore a significant early action of CMT3 that promotes apoptosis in osteoclast lineage cells. (C) 2007 Elsevier Inc. All rights reserved.

    Original languageEnglish
    Pages (from-to)840-845
    Number of pages6
    JournalBiochemical and Biophysical Research Communications
    Volume365
    Issue number4
    Early online date26 Nov 2007
    DOIs
    Publication statusPublished - 25 Jan 2008

    Keywords

    • chemically modified tetracyclines
    • CMT3
    • COL3
    • apoptosis
    • RAW264.7
    • osteoclast
    • mitochondrial transition pore
    • bisphosphonates
    • prenylation
    • bongkrekic acid
    • nitrogen-containing bisphosphonates
    • matrix-metalloproteinase inhibitor
    • in-vitro
    • molecular-mechanism
    • induce apoptosis
    • bone-resorption
    • activation
    • COL-3
    • tetracyclines
    • cancer

    Cite this

    Holmes, S., Smith, S., Borthwick, L., Dunford, J. E., Rogers, M., Bishop, N., & Grabowski, P. S. (2008). CMT3 alters mitochondrial function in murine osteoclast lineage cells. Biochemical and Biophysical Research Communications, 365(4), 840-845. https://doi.org/10.1016/j.bbrc.2007.11.054

    CMT3 alters mitochondrial function in murine osteoclast lineage cells. / Holmes, Simon; Smith, Susan; Borthwick, Lee; Dunford, James Edward; Rogers, Mike; Bishop, Nick; Grabowski, Peter S.

    In: Biochemical and Biophysical Research Communications, Vol. 365, No. 4, 25.01.2008, p. 840-845.

    Research output: Contribution to journalArticle

    Holmes, S, Smith, S, Borthwick, L, Dunford, JE, Rogers, M, Bishop, N & Grabowski, PS 2008, 'CMT3 alters mitochondrial function in murine osteoclast lineage cells', Biochemical and Biophysical Research Communications, vol. 365, no. 4, pp. 840-845. https://doi.org/10.1016/j.bbrc.2007.11.054
    Holmes, Simon ; Smith, Susan ; Borthwick, Lee ; Dunford, James Edward ; Rogers, Mike ; Bishop, Nick ; Grabowski, Peter S. / CMT3 alters mitochondrial function in murine osteoclast lineage cells. In: Biochemical and Biophysical Research Communications. 2008 ; Vol. 365, No. 4. pp. 840-845.
    @article{0a6947a46d36427a8442426c41840993,
    title = "CMT3 alters mitochondrial function in murine osteoclast lineage cells",
    abstract = "Chemically modified tetracyclines (CMTs 1-10) were developed as non-antibiotic inhibitors of matrix metalloproteinases (MMPs). We previously demonstrated that MMP inhibition alone is insufficient to explain the pro-apoptotic action of CMTs in osteoclast lineage cells and we have explored additional mechanisms of action. We compared the characteristics of apoptosis in RAW264.7 murine monocyte and osteoclast cultures treated with pharmacologically relevant concentrations of CMT3 or the bisphosphonate alendronate, which induces osteoclast apoptosis through inhibition of farnesyl diphosphate synthase. CMT3 induced apoptosis rapidly (2-3 h), whereas alendronate-induced apoptosis was delayed (>12 h). CMT3-treated cells did not accumulate unprenylated Rap1A in contrast to cells treated with alendronate. Importantly, CMT3 induced a rapid loss of mitochondrial stability in RAW264.7 cells measured by loss of Mitotracker(R) Red fluorescence, while bongkrekic acid protected polykaryons from CMT3-induced apoptosis. Modulation of mitochondrial function is therefore a significant early action of CMT3 that promotes apoptosis in osteoclast lineage cells. (C) 2007 Elsevier Inc. All rights reserved.",
    keywords = "chemically modified tetracyclines, CMT3, COL3, apoptosis, RAW264.7, osteoclast, mitochondrial transition pore, bisphosphonates, prenylation, bongkrekic acid, nitrogen-containing bisphosphonates, matrix-metalloproteinase inhibitor, in-vitro, molecular-mechanism, induce apoptosis, bone-resorption, activation, COL-3, tetracyclines, cancer",
    author = "Simon Holmes and Susan Smith and Lee Borthwick and Dunford, {James Edward} and Mike Rogers and Nick Bishop and Grabowski, {Peter S.}",
    year = "2008",
    month = "1",
    day = "25",
    doi = "10.1016/j.bbrc.2007.11.054",
    language = "English",
    volume = "365",
    pages = "840--845",
    journal = "Biochemical and Biophysical Research Communications",
    issn = "0006-291X",
    publisher = "Academic Press Inc.",
    number = "4",

    }

    TY - JOUR

    T1 - CMT3 alters mitochondrial function in murine osteoclast lineage cells

    AU - Holmes, Simon

    AU - Smith, Susan

    AU - Borthwick, Lee

    AU - Dunford, James Edward

    AU - Rogers, Mike

    AU - Bishop, Nick

    AU - Grabowski, Peter S.

    PY - 2008/1/25

    Y1 - 2008/1/25

    N2 - Chemically modified tetracyclines (CMTs 1-10) were developed as non-antibiotic inhibitors of matrix metalloproteinases (MMPs). We previously demonstrated that MMP inhibition alone is insufficient to explain the pro-apoptotic action of CMTs in osteoclast lineage cells and we have explored additional mechanisms of action. We compared the characteristics of apoptosis in RAW264.7 murine monocyte and osteoclast cultures treated with pharmacologically relevant concentrations of CMT3 or the bisphosphonate alendronate, which induces osteoclast apoptosis through inhibition of farnesyl diphosphate synthase. CMT3 induced apoptosis rapidly (2-3 h), whereas alendronate-induced apoptosis was delayed (>12 h). CMT3-treated cells did not accumulate unprenylated Rap1A in contrast to cells treated with alendronate. Importantly, CMT3 induced a rapid loss of mitochondrial stability in RAW264.7 cells measured by loss of Mitotracker(R) Red fluorescence, while bongkrekic acid protected polykaryons from CMT3-induced apoptosis. Modulation of mitochondrial function is therefore a significant early action of CMT3 that promotes apoptosis in osteoclast lineage cells. (C) 2007 Elsevier Inc. All rights reserved.

    AB - Chemically modified tetracyclines (CMTs 1-10) were developed as non-antibiotic inhibitors of matrix metalloproteinases (MMPs). We previously demonstrated that MMP inhibition alone is insufficient to explain the pro-apoptotic action of CMTs in osteoclast lineage cells and we have explored additional mechanisms of action. We compared the characteristics of apoptosis in RAW264.7 murine monocyte and osteoclast cultures treated with pharmacologically relevant concentrations of CMT3 or the bisphosphonate alendronate, which induces osteoclast apoptosis through inhibition of farnesyl diphosphate synthase. CMT3 induced apoptosis rapidly (2-3 h), whereas alendronate-induced apoptosis was delayed (>12 h). CMT3-treated cells did not accumulate unprenylated Rap1A in contrast to cells treated with alendronate. Importantly, CMT3 induced a rapid loss of mitochondrial stability in RAW264.7 cells measured by loss of Mitotracker(R) Red fluorescence, while bongkrekic acid protected polykaryons from CMT3-induced apoptosis. Modulation of mitochondrial function is therefore a significant early action of CMT3 that promotes apoptosis in osteoclast lineage cells. (C) 2007 Elsevier Inc. All rights reserved.

    KW - chemically modified tetracyclines

    KW - CMT3

    KW - COL3

    KW - apoptosis

    KW - RAW264.7

    KW - osteoclast

    KW - mitochondrial transition pore

    KW - bisphosphonates

    KW - prenylation

    KW - bongkrekic acid

    KW - nitrogen-containing bisphosphonates

    KW - matrix-metalloproteinase inhibitor

    KW - in-vitro

    KW - molecular-mechanism

    KW - induce apoptosis

    KW - bone-resorption

    KW - activation

    KW - COL-3

    KW - tetracyclines

    KW - cancer

    U2 - 10.1016/j.bbrc.2007.11.054

    DO - 10.1016/j.bbrc.2007.11.054

    M3 - Article

    VL - 365

    SP - 840

    EP - 845

    JO - Biochemical and Biophysical Research Communications

    JF - Biochemical and Biophysical Research Communications

    SN - 0006-291X

    IS - 4

    ER -